{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus\u00ae Panel",
        "MicroScan MICroSTREP plus\u00ae Panel Clarithromycin (0.06-2 mcg/ml)"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K063299",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "November 29, 2006",
    "Summary Letter Received Date": "November 1, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clarithromycin"
    ],
    "Specimen Type(s)": [
        "Bacterial colonies (aerobic streptococci including Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococci (Groups C, F, G), viridans group streptococci)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Manual visual read",
        "Instrument read"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel for Clarithromycin antimicrobial susceptibility testing with manual and instrument read methods.",
    "Indications for Use Summary": "Determination of quantitative and/or qualitative antimicrobial susceptibility of aerobic streptococci, including Streptococcus pneumoniae, to Clarithromycin.",
    "fda_folder": "Microbiology"
}